---
title: ChemDiv vs R2M Pharma, Inc.
slug_a: chemdiv
slug_b: r2mpharma
site: cro
review_signal_gate: closed
canonical_path: /compare/chemdiv/r2mpharma
---

# ChemDiv vs R2M Pharma, Inc.

Side-by-side profile data from each company listing on this directory.

## ChemDiv

- Profile: [/companies/chemdiv](/companies/chemdiv)

ChemDiv — ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.

Services: 15. Modalities: 4. Indications: 6. Locations: 4. Certifications: 2. The strongest documented coverage currently appears in services (15).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Translational Research

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Gene Therapy

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## R2M Pharma, Inc.

- Profile: [/companies/r2mpharma](/companies/r2mpharma)

R2M Pharma, Inc. — R2M Pharma is a medicinal chemistry CRO specializing in small-molecule drug discovery and preclinical development, from hit validation through GLP toxicology studies.

Services: 3. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (3).

### Services

- Discovery Research
- Medicinal Chemistry
- GLP Toxicology

### Modalities

- Small Molecule

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Functional Service Provider (FSP)